Literature DB >> 11262652

Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis.

R W Read1, N A Rao.   

Abstract

The diagnosis of Vogt-Koyanagi-Harada syndrome is hampered by its variable manifestations and the lack of unique ancillary and laboratory findings. In this study, the diagnostic criteria established in 1978 by the American Uveitis Society (AUS) are retrospectively analyzed via their application to a population of 71 consecutive patients, using only those features present at the initial evaluation. All patients were previously diagnosed with Vogt-Koyanagi-Harada syndrome based on the clinical features and course of the disease combined with fluorescein angiography with or without ultrasonography in selected cases. Mean age of all patients was 36.7 years +/- 15.1 years. Fifty (70%) were female and 45 (65%) were Hispanic. Patients presenting acutely, subacutely, and in the chronic stages met the AUS criteria for Vogt-Koyanagi-Harada syndrome in 56%, 48%, and 58% of cases, respectively. Allowance for variation in features, incomplete cases, and modification of the disease by treatment might increase the sensitivity of the criteria. While diagnostic criteria in general are useful for establishing the likelihood that a patient has a disease, the current AUS criteria for the diagnosis of Vogt-Koyanagi-Harada syndrome do not seem adequate.

Entities:  

Mesh:

Year:  2000        PMID: 11262652     DOI: 10.1076/ocii.8.4.227.6457

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

1.  The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid.

Authors:  Nobuyoshi Kitaichi; Hiroko Matoba; Shigeaki Ohno
Journal:  Int Ophthalmol       Date:  2007-01-09       Impact factor: 2.031

2.  A challenged case of Vogt-Koyanagi-Harada syndrome: when dermatological manifestations came first.

Authors:  Inês Coutinho; Catarina Pedrosa; Cristina Santos; Susana Pina; Maria Lisboa; Manuela Bernardo; Isabel Prieto
Journal:  Int Ophthalmol       Date:  2017-03-30       Impact factor: 2.031

3.  Development and Evaluation of Diagnostic Criteria for Vogt-Koyanagi-Harada Disease.

Authors:  Peizeng Yang; Yuanyuan Zhong; Liping Du; Wei Chi; Ling Chen; Rui Zhang; Meifen Zhang; Hong Wang; Hong Lu; Liu Yang; Wenjuan Zhuang; Yan Yang; Lin Xing; Lei Feng; Zhengxuan Jiang; Xiaomin Zhang; Yuqin Wang; Hui Zhong; Liqiong Jiang; Changlin Zhao; Fuzhen Li; Shuang Cao; Xiaoli Liu; Xuan Chen; Yanyun Shi; Weizhong Zhao; Aize Kijlstra
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

4.  Vogt-Koyanagi-Harada disease diagnostic criteria.

Authors:  Narsing A Rao; Somsiri Sukavatcharin; Julie H Tsai
Journal:  Int Ophthalmol       Date:  2007-03-24       Impact factor: 2.031

5.  Classification Criteria for Vogt-Koyanagi-Harada Disease.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

6.  Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.

Authors:  Masaru Miyanaga; Tatushi Kawaguchi; Kentaro Shimizu; Kazunori Miyata; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-05-03       Impact factor: 2.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.